HCA HEALTHCARE, INC.
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.
CAPITALIZATION 12/31/25
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | 44,285 | 115.8 |
| Stockholders' equity | (6,027) | -15.8 |
| Total capitalization | 38,258 | 100.0 |
221,839,800 shares outstanding at 27 April 2026 (cover page of the 10-Q filed 29 April 2026).
LONG-TERM DEBT 12/31/25
| ($ millions) | Amount |
|---|---|
| Long-term debt, incl. current maturities | 44,285 |
| Long-term debt, noncurrent | 41,603 |
| Current maturities | 4,889 |
CAPITAL STOCK 12/31/25
| Common shares authorized | 1,800,000,000 |
| Par or stated value per share ($) | 0.01 |
| Outstanding at 4/27/26 | 221,839,800 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2025 | 2.88 | 10.2 |
| 2024 | 2.64 | 12.0 |
| 2023 | 2.40 | 12.7 |
| 2022 | 2.24 | 11.7 |
| 2021 | 1.92 | 9.1 |
HISTORY AND BUSINESS
HISTORY: State of incorporation not stated in SEC records. Formerly known as HCA Holdings, Inc. (to 5 May 2017); HCA INC/TN (to 24 November 2010); HCA THE HEALTHCARE CO (to 21 May 2001); HCA-THE HEALTHCARE CO (to 14 February 2001).
BUSINESS: Classified by the SEC under Standard Industrial Classification 8062, Services-General Medical & Surgical Hospitals, NEC. Large accelerated filer. Principal executive office: One Park Plz, Nashville, TN 37203. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 12/31/25 | 12/31/24 | 12/31/23 |
|---|---|---|---|
| Revenues | 75,600 | 70,603 | 64,968 |
| Depreciation and amortization | 3,523 | 3,312 | 3,077 |
| Interest expense | 2,248 | 2,061 | 1,938 |
| Income before income taxes | 9,832 | 8,523 | 7,706 |
| Income taxes | 2,050 | 1,866 | 1,615 |
| Net income | 6,784 | 5,760 | 5,242 |
| Earned per share, diluted ($) | 28.33 | 22.00 | 18.97 |
| Dividends per share ($) | 2.88 | 2.64 | 2.40 |
CONSOLIDATED BALANCE SHEET
| ($ millions) | 12/31/25 | 12/31/24 |
|---|---|---|
| Cash and equivalents | 1,040 | 1,933 |
| Receivables, net | 10,867 | 10,751 |
| Inventories | 1,652 | 1,738 |
| Total current assets | 15,783 | 16,414 |
| Property, plant and equipment, net | 31,141 | 29,414 |
| Total assets | 60,720 | 59,513 |
| Total current liabilities | 16,350 | 15,177 |
| Long-term debt | 41,603 | 38,333 |
| Stockholders' equity | (6,027) | (2,499) |
| Total liabilities and equity | 60,720 | 59,513 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Capital expend. | Free cash flow | Total assets | Total liabilities | Total debt | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/31/25 | 75,600 | – | 6,784 | 9.0 | 28.33 | 2.88 | 12,636 | 4,944 | 7,692 | 60,720 | 63,491d | 44,285 | (6,027) | -112.6 | -7.35 |
| 12/31/24 | 70,603 | – | 5,760 | 8.2 | 22.00 | 2.64 | 10,514 | 4,875 | 5,639 | 59,513 | 58,958d | 43,031 | (2,499) | -230.5 | -17.22 |
| 12/31/23 | 64,968 | – | 5,242 | 8.1 | 18.97 | 2.40 | 9,431 | 4,744 | 4,687 | 56,211 | 55,151d | 39,593 | (1,774) | -295.5 | -22.32 |
| 12/31/22 | 60,233 | – | 5,643 | 9.4 | 19.15 | 2.24 | 8,522 | 4,395 | 4,127 | 52,438 | 52,511d | 38,084 | (2,767) | -203.9 | -13.76 |
| 12/31/21 | 58,752 | – | 6,956 | 11.8 | 21.16 | 1.92 | 8,959 | 3,577 | 5,382 | 50,742 | 49,253d | 34,579 | (933) | -745.6 | -37.06 |
| 12/31/20 | 51,533 | – | 3,754 | 7.3 | 10.93 | 0.43 | 9,232 | 2,835 | 6,397 | 47,490 | 44,598d | 31,004 | 572 | 656.3 | 54.20 |
| 12/31/19 | 51,336 | – | 3,505 | 6.8 | 10.07 | 1.60 | 7,602 | 4,158 | 3,444 | 45,058 | 45,623 | 33,722 | (2,808) | -124.8 | -12.01 |
| 12/31/18 | 46,677 | – | 3,787 | 8.1 | 10.66 | 1.40 | 6,761 | 3,573 | 3,188 | 39,207 | 42,125 | 32,821 | (4,950) | -76.5 | -6.63 |
| 12/31/17 | 43,614 | – | 2,216 | 5.1 | 5.95 | – | 5,426 | 3,015 | 2,411 | 36,593 | 41,588 | 33,058 | (6,806) | -32.6 | -4.86 |
| 12/31/16 | 41,490 | – | 2,890 | 7.0 | 7.30 | – | 5,653 | 2,760 | 2,893 | 33,758 | 39,391 | 31,376 | (7,302) | -39.6 | -4.30 |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
HCA Healthcare, Inc.
CIK 860730 · EIN 27-3865930
PRINCIPAL OFFICE:
One Park Plz, Nashville, TN 37203
Tel.: 6153449551
INCORPORATED:
–
INDUSTRY (SEC SIC CODE):
8062 · Services-General Medical & Surgical Hospitals, NEC
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 12/31/25, filed 10 February 2026
FORMER NAMES:
HCA Holdings, Inc.; HCA INC/TN; HCA THE HEALTHCARE CO
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/10/26) · 10-K FY2024 (filed 2/14/25) · 10-K FY2023 (filed 2/16/24) · 10-K FY2022 (filed 2/17/23) · 10-K FY2021 (filed 2/18/22) · 10-K FY2020 (filed 2/19/21) · 10-K FY2019 (filed 2/20/20) · 10-K FY2018 (filed 2/21/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.